Moreover, a high value of α1/α2 was also shown by mouse No.2 from the anti-CTLA-4-therapy group (the tumor volume of 191 mm3), which, despite the initially large tumor, demonstrated the tumor growth inhibition starting from day 11 and reduction in the tumor node size. This evidence concerns the gene CTLA4 and neoplasm.